Medications
FDA OKs first generic for Gleevec leukemia pill
U.S. regulators have approved the first generic version of one of the first very effective—and expensive—cancer drugs, Gleevec, which costs about $10,000 a month.
Dec 4, 2015
0
6
Acute Lymphoblastic Leukemia
Oncology & Cancer
Inherited gene variation linked to an increased risk of the most common childhood cancer
Researchers studying two generations of a family affected by pediatric acute lymphoblastic leukemia (ALL) have identified an inherited variation in the ETV6 gene that is associated with an increased risk of developing the ...
Oct 27, 2015
0
142
Oncology & Cancer
New finding offers clues for blocking cancer gene
A new study suggests a potential new way to block one of the most common cancer-causing genes, without causing severe side effects.
Oct 27, 2015
0
29
Medical research
Orange lichens are potential source for anticancer drugs
An orange pigment found in lichens and rhubarb called parietin may have potential as an anti-cancer drug, scientists at Winship Cancer Institute of Emory University have discovered.
Oct 19, 2015
0
207
Oncology & Cancer
From molecular case studies: Genomics of exceptional responder to NOTCH inhibitor
Normal T-cell development requires Notch signaling but hyperactivity can lead to cancer. Drugs that inhibit Notch, such as gamma-secretase inhibitors (GSIs), are currently being tested in different cancer types but clinical ...
Oct 6, 2015
0
11
Medications
Medicare will cover expensive new leukemia medication
(HealthDay)—Medicare will pay for a new, expensive cancer medication that costs about $178,000 for a standard course of treatment, the Obama administration says.
Aug 11, 2015
0
10
Oncology & Cancer
New treatment options for a fatal leukemia
In industrialized countries like in Europe, acute lymphoblastic leukemia is the most common form of cancer in children. An international research consortium lead by pediatric oncologists from the Universities of Zurich and ...
Jul 27, 2015
0
45
Oncology & Cancer
New approach to treating B-cell acute lymphoblastic leukemia shows promise
A new compound that locks a disease-related protein into an inactive position stifled the growth of an aggressive form of leukemia in laboratory and animal tests, researchers at Dana-Farber Cancer Institute and other institutions ...
Jul 13, 2015
0
34
Oncology & Cancer
Inactivating a single enzyme could effectively eradicate an aggressive form of leukemia
EPFL scientists show how inactivating a single enzyme could effectively eradicate an aggressive form of leukemia. The principles could apply to other cancers as well.
Jun 22, 2015
0
324
Oncology & Cancer
Researchers identify gene mutation that can trigger lymphoblastic leukemia
Two medical researchers from the Children's Hospital of Michigan and the Wayne State University School of Medicine have published the results of a nearly 10-year investigation that identified a key gene mutation that can ...
Jun 18, 2015
0
53
